Additionally, IPA® predicted elevated activation of brain-derived neurotrophic factor (BDNF, Figure 6b), widely considered a neuroprotective protein and the focus of gene therapy for glaucoma [63]. The gene discussed is BDNF; the disease is glaucoma.